AMAG Pharmaceuticals Announces Third Quarter 2018 Financial Results and Provides Corporate Update
01 nov. 2018 07h00 HE
|
AMAG Pharmaceuticals, Inc.
Achieved strong third quarter financial performance and increased full year 2018 guidance Acquired AMAG-423 for severe preeclampsia, reaffirming the company's focus on...
AMAG Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call and Webcast on Thursday, November 1, 2018 at 8:00 a.m. ET
25 oct. 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its third quarter 2018 financial results will be released on Thursday, November 1,...
AMAG Pharmaceuticals and Endoceutics Announce Presentation at the 2018 Annual Meeting of The North American Menopause Society on the Effect of Time Since Menopause, Age and Previous Hormone Therapy on the Response to Intravaginal Prasterone
04 oct. 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
Study Suggests that While All Postmenopausal Women Benefit from Treatment with Prasterone (INTRAROSA®), Women Experience Greatest Relief of Moderate to Severe Dyspareunia when started on INTRAROSA®...
AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia
26 sept. 2018 06h30 HE
|
AMAG Pharmaceuticals, Inc.
Currently no FDA-approved treatment options for severe preeclampsia, a leading cause of maternal and neonatal mortality Acquisition expands AMAG’s maternal health portfolio and commitment to...
AMAG Pharmaceuticals Partners With Emmy-Nominated Actress Cheryl Hines and Dr. Marla Shapiro to Start a Conversation About an Often Unrecognized and Untreated Medical Condition, Painful Sex Due to Menopause
20 sept. 2018 09h15 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that together with Emmy®-nominated actress Cheryl Hines and leading family medicine and...
AMAG Pharmaceuticals Pays Off $475 Million of Senior Secured Notes
06 sept. 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that it has redeemed $475 million of its outstanding 7.875% senior notes, using the...
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
23 août 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Aug. 23, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate in the following investor conferences: B. Riley...
AMAG Pharmaceuticals Completes Divestiture of Cord Blood Registry®
06 août 2018 16h30 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it has closed the previously announced divestiture of Cord Blood Registry (CBR®) to GI...
AMAG Pharmaceuticals Appoints Brian Robinson, M.D. as Senior Vice President of Medical Affairs
06 août 2018 07h30 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Brian Robinson, M.D. as senior vice president, medical affairs,...
AMAG Pharmaceuticals Announces Second Quarter 2018 Financial Results and Provides Corporate Update
02 août 2018 07h00 HE
|
AMAG Pharmaceuticals, Inc.
Achieved 12% revenue growth and record quarterly sales Raising full year revenue and adjusted EBITDA guidance for pharmaceutical products Conference call scheduled for 8:00 a.m. ET today ...